Article
Blood-based screening for HPV-associated cancers
2024-01-05
Abstract excerpt
<h4>Background</h4> HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated cancer in the United States yet unlike cervical cancer lacks a screening test. HPV+OPSCCs are presumed to start developing 10-15 years prior to clinical diagnosis. Circulating tumor HPV DNA (ctHPVDNA) is a sensitive and specific biomarker for HPV+OPSCC. Taken together, blood-based screening for HPV+OPSCC may be f...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3eb54de6-afd3-538c-b57b-f0bd7e1450f8
- DOI
- 10.1101/2024.01.04.24300841
